The synergistic mechanisms of propofol with cisplatin or doxorubicin in human ovarian cancer cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
The synergistic mechanisms of propofol with cisplatin or doxorubicin in human ovarian cancer cells ; volume:17 ; number:1 ; day:14 ; month:9 ; year:2024 ; pages:1-16 ; date:12.2024
Journal of ovarian research ; 17, Heft 1 (14.9.2024), 1-16, 12.2024
- Urheber
-
Sue, Sung-How
Tseng, Wei-Cheng
Wu, Zih-Syuan
Huang, Shih-Ming
Chen, Jia-Lin
Wu, Zhi-Fu
Lai, Hou-Chuan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-024-01509-x
- URN
-
urn:nbn:de:101:1-2411282100272.584079420223
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sue, Sung-How
- Tseng, Wei-Cheng
- Wu, Zih-Syuan
- Huang, Shih-Ming
- Chen, Jia-Lin
- Wu, Zhi-Fu
- Lai, Hou-Chuan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Doxorubicin-induced ovarian toxicity
Intraperitoneal cisplatin and doxorubicin as maintenance chemotherapy for unresectable ovarian cancer: a case report
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma
Induktion der MDR1-Genexpression beim Ovarialkarzinom unter zytostatischer Behandlung mit Cisplatin und Doxorubicin
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Doxorubicin-induced ovarian toxicity
Intraperitoneal cisplatin and doxorubicin as maintenance chemotherapy for unresectable ovarian cancer: a case report
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma
Induktion der MDR1-Genexpression beim Ovarialkarzinom unter zytostatischer Behandlung mit Cisplatin und Doxorubicin
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Doxorubicin-induced ovarian toxicity
Intraperitoneal cisplatin and doxorubicin as maintenance chemotherapy for unresectable ovarian cancer: a case report
Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin
Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicin
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Systemic chemotherapy with doxorubicin, cisplatin and capecitabine for metastatic hepatocellular carcinoma
Pegylated liposomal doxorubicin in patients with epithelial ovarian cancer
The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma
Induktion der MDR1-Genexpression beim Ovarialkarzinom unter zytostatischer Behandlung mit Cisplatin und Doxorubicin
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma
Self‐Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma